Strangely behaving fluidic oscillator gan Peszynski K., Tesař V.

Cael y testun llawn

Damage is independent of disease activity in systemic vasculitis gan McRorie, E, Luqmani, R, Dadoniene, J, Rychlik, I, Tesar, V, Nowack, R

Prospective clinical trial of Gusperimus (deoxyspergualin) in refractory Wegener's granulomatosis gan Flossmann, O, Baslund, B, Bruchfeld, A, Cohen Tervaert, J, Heinzel, P, Hellmich, B, Luqmani, R, Tesar, V, Jayne, D

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. gan Flossmann, O, Baslund, B, Bruchfeld, A, Tervaert, J, Hall, C, Heinzel, P, Hellmich, B, Luqmani, R, Nemoto, K, Tesar, V, Jayne, DR

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP). gan Haynes, R, Staplin, N, Emberson, J, Herrington, W, Tomson, C, Agodoa, L, Tesar, V, Levin, A, Lewis, D, Reith, C, Baigent, C, Landray, M

Evaluating the contribution of the cause of kidney disease to prognosis in ckd: Results from the Study of Heart and Renal Protection (SHARP) gan Haynes, R, Staplin, N, Emberson, J, Herrington, W, Tomson, C, Agodoa, L, Tesar, V, Levin, A, Lewis, D, Reith, C, Baigent, C, Landray, M

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS gan Jones, R, Tervaert, J, Hauser, T, Luqmani, R, Peh, C, Savage, C, Segelmark, M, Tesar, V, Van Paassen, P, Walsh, M, Walsh, D, Westman, K, Jayne, D

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection. gan Herrington, W, Emberson, J, Staplin, N, Blackwell, L, Fellström, B, Walker, R, Levin, A, Hooi, L, Massy, Z, Tesar, V, Reith, C, Haynes, R, Baigent, C, Landray, M

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. gan Jones, R, Tervaert, J, Hauser, T, Luqmani, R, Morgan, MD, Peh, C, Savage, C, Segelmark, M, Tesar, V, van Paassen, P, Walsh, D, Walsh, M, Westman, K, Jayne, DR

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. gan de Groot, K, Harper, L, Jayne, DR, Flores Suarez, L, Gregorini, G, Gross, W, Luqmani, R, Pusey, C, Rasmussen, N, Sinico, R, Tesar, V, Vanhille, P, Westman, K, Savage, C

Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial gan Harper, L, De Groot, K, Jayne, D, Flores Suarez, L, Gregorini, G, Gross, W, Luqmani, R, Pusey, C, Rasmussen, N, Sinico, R, Tesar, V, Vanhille, P, Westman, K, Savage, C

Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis gan Scott, J, White, A, Walsh, C, Aslett, L, Rutherford, MA, Ng, J, Judge, C, Sebastian, K, O’Brien, S, Kelleher, J, Power, J, Conlon, N, Moran, SM, Luqmani, RA, Merkel, PA, Tesar, V, Hruskova, Z, Little, MA

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. gan Suppiah, R, Mukhtyar, C, Flossmann, O, Alberici, F, Baslund, B, Batra, R, Brown, D, Holle, J, Hruskova, Z, Jayne, DR, Judge, A, Little, M, Palmisano, A, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. gan Harper, L, Morgan, MD, Walsh, M, Hoglund, P, Westman, K, Flossmann, O, Tesar, V, Vanhille, P, de Groot, K, Luqmani, R, Flores-Suarez, L, Watts, R, Pusey, C, Bruchfeld, A, Rasmussen, N, Blockmans, D, Savage, C, Jayne, D

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index gan Suppiah, R, Flossmann, O, Mukhtyar, C, Alberici, F, Baslund, B, Brown, D, Hasan, N, Holle, J, Hruskova, Z, Jayne, D, Judge, A, Little, M, Merkel, P, Palmisano, A, Seo, P, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA) gan Suppiah, R, Flossman, O, Mukhtyar, C, Alberici, F, Baslund, B, Brown, D, Hasan, N, Holle, J, Hruskova, Z, Jayne, D, Judge, A, Little, M, Merkel, P, Palmisano, A, Seo, P, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. gan Suppiah, R, Flossman, O, Mukhtyar, C, Alberici, F, Baslund, B, Brown, D, Hasan, N, Holle, J, Hruskova, Z, Jayne, D, Judge, A, Little, M, Merkel, P, Palmisano, A, Seo, P, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts gan Yates, M, Watts, R, Bajema, I, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Little, MA, Luqmani, RA, Mahr, A, Merkel, P, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, KWA, Vaglio, A, Yalçındağ, N, Jayne, DR, Mukhtyar, C

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis gan Yates, M, Watts, R, Bajema, I, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Little, M, Luqmani, R, Mahr, A, Merkel, P, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Yalçındağ, N, Jayne, D, Mukhtyar, C

EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS gan Yates, M, Watts, R, Nilufer, N, Bajema, I, Little, M, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Mooney, J, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Luqmani, R, Mahr, A, Merkel, P, Mills, J, Jayne, D, Mukhtyar, C